No CrossRef data available.
Article contents
Postexposure Prophylaxis for Human Immunodeficiency Virus: Frequency of Initiation and Completion of Newly Recommended Regimen
Published online by Cambridge University Press: 02 January 2015
Abstract
Recent evidence demonstrating the efficacy of zidovudine, as well as experience with protease inhibitors, led to revision of recommendations for occupational exposures to human immunodeficiency virus-infected blood. At our hospital, this resulted in significant increases in rates of reported exposures and prophylaxis initiation. Among 10 healthcare workers given three-drug, protease-inhibitor-containing regimens, five completed 4 weeks, two completed 4 weeks of two drugs, and three stopped due to intolerance. Three workers missed work due to side effects
- Type
- Concise Communications
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 1998
References
- 5
- Cited by